top of page
background.jpg
Highlighting New Advances
in Immuno-Oncology Management

​

A Summary Report from the 2025 ESMO
Immuno-Oncology Congress (December 10-12)
Mise à jour de la
prise en charge en
immuno-oncologique

​

Résumé du Congrès 2025 de
l’ESMO Immuno-oncologie (10 au 12 décembre)
background.jpg

SNELL Medical Communication acknowledges that it has received arm’s length educational funding from Apobiologix to support the development and distribution of this educational publication. The acceptance of funding was contingent upon the sponsors’ adherence to SNELL Medical Communication’s policy designed to preserve the educational integrity of the publication. This policy ensures that the authors will at all times exercise unrestricted, rigorous, scientific independence free of interference from any other party. 

​

©2026 Published by SNELL Medical Communication Inc. through arm’s length educational funding from Apobiologix. All rights reserved. The opinions expressed in this publication do not necessarily reflect those of the publisher or its educational sponsor, but rather are those of the authors based on the available scientific literature. The administration of any therapies discussed or referred to should always be consistent with the recognized prescribing information as required in Canada. SNELL Medical Communication Inc. is committed to the development of superior Continuing Medical Education.

bottom of page